Name: CLEARMIND MEDICINE INC (CMND) Stock
Brand: CLEARMIND MEDICINE INC
Rating: 0.5 (3 reviews)

CMND Latest News, Press Relases and Analysis

All

Press Releases

3 hours ago - By: Chartmill - Mentions: AEO AEMD PSTG KXIN ...

Which stocks are gapping on Wednesday?

5 hours ago - By: Chartmill - Mentions: CEP ACHC CMCT CAPR ...

Get insights into the top gainers and losers of Wednesday's pre-market session.

a day ago - By: Chartmill - Mentions: PLUG INTC NVDA BYND ...

Curious about the most active stocks on Tuesday?

a day ago - By: Clearmind Medicine Inc.

Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder

a day ago - By: Clearmind Medicine Inc.

Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder

2 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial

2 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Charges Forward in Alcoholism Treatment: Positive Cohort Data, Full DSMB Approval, and New Elite Site Joins the Clinical Trial

8 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial

8 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial

9 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review

9 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine's Data and Safety Monitoring Board Unanimously Approves Continuation of Phase I/IIa Clinical Trial for CMND-100 Following Positive Interim Safety Review

13 days ago - By: SciSparc Ltd - Mentions: SPRC NTLX.CA

SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

13 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site

13 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Accelerate FDA-Approved Alcohol Use Disorder Clinical Trial by Activating Fifth Elite Global Medical Site

15 days ago - By: Chartmill - Mentions: PLUG JACK CANF JAGX ...

Tuesday's after hours session: top gainers and losers

15 days ago - By: Chartmill - Mentions: SRDX GLMD KXIN APLT ...

On Tuesday, there are stocks with unusual volume. Let's take a look.

15 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

15 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

16 days ago - By: Chartmill - Mentions: SRDX CMCT ASRT OTLK ...

On Monday, there are stocks with unusual volume. Let's take a look.

16 days ago - By: Clearmind Medicine Inc. - Mentions: NTLX.CA SPRC

Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

16 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression

19 days ago - By: Benzinga - Mentions: PTN ZYXI AVXL CDTX ...

12 Health Care Stocks Moving In Friday's Intraday Session

20 days ago - By: Chartmill - Mentions: PLUG NVDA OPEN RUBI ...

Thursday's session: most active stocks

20 days ago - By: Benzinga

Clearmind Medicine (CMND) Stock Soars Thursday: What's Going On?

20 days ago - By: Chartmill - Mentions: RUBI SLRX FTCI SWAG ...

The trading volume of these stocks is deviating from the norm in today's session.

20 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

20 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

21 days ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces Notice of Patent Publication for Depression Treatment

21 days ago - By: Clearmind Medicine Inc.

CLEARMIND MEDICINE INC (CMND) Stock News

CMND Latest News, Press Relases and Analysis